From owner-doc-jp@jp.FreeBSD.org Fri May 16 05:39:28 2014
Received: (from daemon@localhost)
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) id s4FKdSP93483;
	Fri, 16 May 2014 05:39:28 +0900 (JST)
	(envelope-from owner-doc-jp@jp.FreeBSD.org)
Received: from dq265c0.bjxykjf.com ([31.131.30.213])
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) with ESMTP/inet id s4FKdOd93474
	for <doc-jp@jp.freebsd.org>; Fri, 16 May 2014 05:39:26 +0900 (JST)
	(envelope-from WeeklyPick@bjxykjf.com)
Received: by 0089a335.dq265c0.bjxykjf.com
	(amavisd-new, port 7147) with ESMTP id 00CVQTCIN89A3UDWYMDP35;
	for <doc-jp@jp.freebsd.org>; Thu, 15 May 2014 13:39:23 -0700
Message-ID: <14713190200661474328274500@dq265c0.bjxykjf.com>
From: "Weekly Pick" <WeeklyPick@bjxykjf.com>
To: <doc-jp@jp.FreeBSD.org>
Content-Language: en-us
MIME-Version: 1.0
Content-Transfer-Encoding: 8bit
Content-Type: text/plain; charset="UTF-8"
Reply-To: doc-jp@jp.FreeBSD.org
Precedence: list
Date: Thu, 15 May 2014 13:39:23 -0700
X-Sequence: doc-jp 122734
Subject: [doc-jp 122734] You'll Thank Me For This
Sender: owner-doc-jp@jp.FreeBSD.org
X-Originator: WeeklyPick@bjxykjf.com
X-Distribute: distribute version 2.1 (Alpha) patchlevel 24e+060209

http://www.bjxykjf.com/147/28/43/274/500.12tt9020066AAF1.html

Our Subscriber Alert for a HOT MMJ Stock  PIHN *We are very excited to share -
Our New MMJ Pick - with our subscribers!*
You may not have seen but our pick *PIHN*, one of the leading MMJ
organizations in the states, has recently released some MAJOR NEWS.
*PIHN*signed an agreement to utilize 70 acres of hemp farmland in
Kentucky to secure harvested material for extraction!

*PIHN* also announced the purchase of over 2,000 lbs of hemp and set a date
for their planting ceremony and beginning of their production, proving
their forward moving progress!

Investor interest started to pour in causing *PIHN* to trade over *10
million shares* in Thursday's session. The positive news releases have
gotten investors and traders in this HOT secto r to put *PIHN* on their
radars!

*-  PIHN is in one of the Hottest Markets on Wall Street -*

http://www.bjxykjf.com/147/28/43/274/500.12tt9020066AAF1.html

  *About PIHN*  *THE FUTURE OF MEDICINAL CANNABINOID OILS*  
ProCannas core business focuses on the manufacture and distribution of 
new, pharmaceutical grade cannabinoid based products for medicinal use, 
collectively called the Cannatrol™ line. We are perfecting two different
 versions of product formulations, including one containingTetrahydrocannabinol
 (THC) and one without. The version containing THC ("Cannatrol TM")
 will be manufactured and available only in the few states that allow THC
 based products to be distributed. The plants we will use for extraction of
 the non-THC based products are provided exclusively by our offshore
 (India) affiliate, and various versions of such formulations have been used 
effectively within the Eastern medical system for over 5000 years.

A second area of concentration for the Company focuses on the acquisition
of exi sting medical marijuana growing and distribution companies
exhibiting positive cash flow. These acquisitions are planned only in
states such as California and Colorado where such activities are legal. We
believe that the addition of these acquired companies and operations will
place us on a faster track to revenue and profit thus adding considerable
value. Also, our affiliate in India already owns a farm which grows organic
herbs, coconuts and other medicinal plants and this farm is expected to
become further integrated with the ProCannas operation, subject to funding.
As of the date of this summary, the Company is in talks with different
prospective sellers and investors about such acquisitions.

http://www.bjxykjf.com/147/28/43/274/500.12tt9020066AAF1.html 

 *Untapped Market Opportunity* 
We believe that our opportunity in this emerging market is significant for
several important reasons. First, due to recent changes in the law
regarding the medical use of marijuana, coupled with studies and a strong
body of evidence highlighting that THC is not the significant component for
medicinal use, doors are opening for innovation. Laws are expected to
become even more favorable for companies like ProCannas.

Second, our internal analysis shows that there are virtually no consistent
pharmaceutical like "doctor-only" formulations of marijuana and cannabis
products yet available, and we believe that to our knowledge, there are no
other products with the pharmaceutical purity, strength and formulation are
present in the market and that we are in a first-to-market position with
this product lin e.  *PIHN has a "BUY" rating on Barchart with HUGE
Potential*  *PIHN is looking at a gain of 11,100.00% since 5/16/13*

http://www.bjxykjf.com/147/28/43/274/500.12tt9020066AAF1.html

